Temporary Full-Time

We are seeking an outstanding, motivated student to join our team to assist our research efforts in normal and malignant hematopoiesis study. 

The overarching goal of our laboratory is to understand the control of stem cells in development and diseases.  Our research group is focused on uncovering novel mechanisms of post-transcriptional and translational regulation during normal and malignant hematopoiesis.  The highly competitive research plan encompasses of several largely supported projects involving the use of human and mouse models, primary patient samples of hematologic malignancies and cutting-edge technologies. By using animal models and genomic approaches for identification of novel translational regulators in leukemia (Vu et al. Nat Gen 2017, Vu et al. Nat Med 2017), the Vu lab investigates novel molecular mechanisms underpinning leukemogenesis and control of hematopoietic stem cells.  The Vu lab is a part of Terry Fox Laboratory, the world class and highly collaborative research unit at BC Cancer and the Faculty of Pharmaceutical Sciences, UBC.  The Vu lab has a strong interest and expertise in translational cancer research with several collaborations at major international institutions worldwide.

Qualified candidates should have a bachelor/or MSc degree in Life Sciences preferably in biochemistry, molecular and cell biology and working knowledge of lab skills and techniques such as pipetting, cell & tissue culture, PCR, RT-qPCR, RNA extraction, Western Blot, immunostaining & flow cytometry.  Experience working with animal models is desirable.

Salary will be commensurate with qualifications and experience.

To Apply:

Please send a statement of research interest, curriculum vitae, transcripts and contact details for 3 referees to:

Ly P. Vu, PhD

Scientist, Terry Fox Laboratory, BC Cancer

Assistant Professor, Faculty of Pharmaceutical Sciences, UBC
Email: lvu[at]bccrc.ca

This position will remain open until filled.

This is a temporary position with a possibility of extension.

Back to top